Private equity powerhouse Carlyle has taken a stake in one of China's largest infant formula makers, a strong vote of confidence for a sector that has been plagued by controversy over tainted milk powder and other dairy products during last year's
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.